Win big when you join a Risperdal class action lawsuit
When Johnson & Johnson released Risperdal in the market, everyone was thrilled. After all, there are not too many medicines that claim to treat schizophrenia. The problem started when Risperdal was recommended for minors aged between 13 and 17 and among minors between the ages of 10 and 17 for the treatment of bipolar disorder. […]

